Given that leukemia development requires the acquisition of multiple genetic aberrations, the study of primary cells from patient leukemic samples does not allow easy discrimination of the impact of RUNX1-ETO alone on the gene regulatory network of normal blood progenitor cells. This evidence concerns the gene RUNX1 and leukemia.